Conversely, the steatogenic allele in GCKR locus seems to protect against the development of chronic kidney disease among T2D individuals,137, 138 consistently with the GCKR‐related hypoglycaemic effect observed in nondiabetic individuals. This evidence concerns the gene GCKR and chronic kidney disease.